Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474–9.

CAS  Article  Google Scholar 

Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17:241–6.

CAS  Article  Google Scholar 

Gannon K, Glover L, O’Neill M, Emberton M. Men and chronic illness: a qualitative study of LUTS. J Health Psychol. 2004;9:411–20.

Article  Google Scholar 

Ornaghi PI, Porreca A, Sandri M, Sciarra A, Falsaperla M, Ludovico GM, et al. Features of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases. Prostate Cancer and Prostatic Diseases. 2022. https://pubmed.ncbi.nlm.nih.gov/35869394/

Prezioso D, Catuogno C, Galassi P, D’Andrea G, Castello G, Pirritano D. Life-style in patients with LUTS suggestive of BPH. Eur Urol. 2001;40:9–12.

Article  Google Scholar 

Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, et al. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int. 2015;115:24–31.

Article  Google Scholar 

Teoh JY, Chan CK, Wang MH, Leung CH, Chan ES, Chiu PK, et al. Transurethral resection of prostate for acute urinary retention is linked to shorter survival in younger men. Asian J Androl. 2019;21:468–72.

Article  Google Scholar 

Yee CH, Yip JSY, Cheng NMY, Kwan CH, Li KM, Teoh JYC, et al. The cardiovascular risk factors in men with lower urinary tract symptoms. World J Urol. 2019;37:727–33.

CAS  Article  Google Scholar 

Semczuk-Kaczmarek K, Platek AE, Szymanski FM. Co-treatment of lower urinary tract symptoms and cardiovascular disease - where do we stand? Cent Eur J Urol. 2020;73:42–5.

CAS  Google Scholar